Zur Rose Group grows 28 per cent in the first quarter of 2019
(WorldNews Switzerland)

Press release Zur Rose Group grows 28 per cent in the first quarter of 2019 - 45.9 per cent sales growth in Germany including medpex - Stable increase in revenue in Switzerland - Successful rollout of the marketplace model in France - Revenue forecast for the year as a whole reaffirmed The Zur Rose Group continued its path of growth in the first quarter of 2019 as planned. After adding in medpex revenue, the Group achieved an increase in revenue of 28.1 per cent to CHF 381.1 million. In Germany, revenue in local currency increased by 45.9 per cent to EUR 212.8 million. The non-prescription drug business was the main driver of growth: the mail-order business of medpex in particular performed...